Potassium, zinc, chromium, selenium, and vanadium each have Moderate interactions with diabetes drugs and/or blood thinners
Maintenance planning Clear discussion about how to maintain results if the medication is reduced or discontinued, with emphasis on sustainable habits and metabolic health, not just the number on the scale
Non-Alcoholic Fatty Liver Disease (NAFLD) Hepatic lipid accumulation driven by insulin resistance and impaired lipid export
L-carnitine is generally considered safe for most people, but it can interact with thyroid function in specific ways
The goal is to maximize the weight loss while being able to get patients off the drug in the future in a way that they dont feel like theyre going to regain the weight. Weight loss using GLP-1 medication varies by individual, but data suggest it is from 10% to 20% of total body weight over one year
Provided by : LibreTexts